Tariot PN - Search Results

1

Chronic divalproex sodium use and brain atrophy in Alzheimer disease.

Fleisher AS, Truran D, Mai JT, Langbaum JB, Aisen PS, Cummings JL, Jack CR Jr, Weiner MW, Thomas RG, Schneider LS, Tariot PN; Alzheimer's Disease Cooperative Study. Fleisher AS, et al. Among authors: tariot pn. Neurology. 2011 Sep 27;77(13):1263-71. doi: 10.1212/WNL.0b013e318230a16c. Epub 2011 Sep 14. Neurology. 2011. PMID: 21917762 Free PMC article. Clinical Trial.

2

Therapy with l-deprenyl (selegiline) and relation to abuse liability.

Schneider LS, Tariot PN, Goldstein B. Schneider LS, et al. Among authors: tariot pn. Clin Pharmacol Ther. 1994 Dec;56(6 Pt 2):750-6. doi: 10.1038/clpt.1994.205. Clin Pharmacol Ther. 1994. PMID: 7995017 Review.

3

Emerging drugs for Alzheimer's disease. Mechanisms of action and prospects for cognitive enhancing medications.

Schneider LS, Tariot PN. Schneider LS, et al. Among authors: tariot pn. Med Clin North Am. 1994 Jul;78(4):911-34. doi: 10.1016/s0025-7125(16)30142-0. Med Clin North Am. 1994. PMID: 8022237 Review.

4

Anticonvulsant and other non-neuroleptic treatment of agitation in dementia.

Tariot PN, Schneider LS, Katz IR. Tariot PN, et al. J Geriatr Psychiatry Neurol. 1995 Oct;8 Suppl 1:S28-39. doi: 10.1177/089198879500800105. J Geriatr Psychiatry Neurol. 1995. PMID: 8561842 Review.

5

Treating Alzheimer's disease. Pharmacologic options now and in the near future.

Tariot PN, Schneider L, Porsteinsson AP. Tariot PN, et al. Postgrad Med. 1997 Jun;101(6):73-6, 81, 84 passim. doi: 10.3810/pgm.1997.06.224. Postgrad Med. 1997. PMID: 9194867

6

A longitudinal study of behavioral pathology across five levels of dementia severity in Alzheimer's disease: the CERAD Behavior Rating Scale for Dementia. The Alzheimer's Disease Cooperative Study.

Patterson MB, Mack JL, Mackell JA, Thomas R, Tariot P, Weiner M, Whitehouse PJ. Patterson MB, et al. Alzheimer Dis Assoc Disord. 1997;11 Suppl 2:S40-4. Alzheimer Dis Assoc Disord. 1997. PMID: 9236951 Clinical Trial.

7

A 5-month, randomized, placebo-controlled trial of galantamine in AD. The Galantamine USA-10 Study Group.

Tariot PN, Solomon PR, Morris JC, Kershaw P, Lilienfeld S, Ding C. Tariot PN, et al. Neurology. 2000 Jun 27;54(12):2269-76. doi: 10.1212/wnl.54.12.2269. Neurology. 2000. PMID: 10881251 Clinical Trial.

8

Treatment of agitation in AD: a randomized, placebo-controlled clinical trial.

Teri L, Logsdon RG, Peskind E, Raskind M, Weiner MF, Tractenberg RE, Foster NL, Schneider LS, Sano M, Whitehouse P, Tariot P, Mellow AM, Auchus AP, Grundman M, Thomas RG, Schafer K, Thal LJ; Alzheimer's Disease Cooperative Study. Teri L, et al. Neurology. 2000 Nov 14;55(9):1271-8. doi: 10.1212/wnl.55.9.1271. Neurology. 2000. PMID: 11087767 Clinical Trial.

9

Pharmacologic therapy for behavioral symptoms of Alzheimer's disease.

Tariot PN, Ryan JM, Porsteinsson AP, Loy R, Schneider LS. Tariot PN, et al. Clin Geriatr Med. 2001 May;17(2):359-76. doi: 10.1016/s0749-0690(05)70073-2. Clin Geriatr Med. 2001. PMID: 11375140 Review.

10

Pharmacotherapy of Alzheimer's disease: is there a need to redefine treatment success?

Winblad B, Brodaty H, Gauthier S, Morris JC, Orgogozo JM, Rockwood K, Schneider L, Takeda M, Tariot P, Wilkinson D. Winblad B, et al. Int J Geriatr Psychiatry. 2001 Jul;16(7):653-66. doi: 10.1002/gps.496. Int J Geriatr Psychiatry. 2001. PMID: 11466744 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

500 results

Search Page

Filters